Replies to post #49735 on NanoViricides Inc. (NNVC)

[BonelessCat]

Pursuant to the terms of the Exchange, ECMM acquired NVI in exchange for an aggregate of 80,000,000 newly issued shares of ECMM common stock, resulting in an aggregate of 100,000,000 shares of ECMM common stock issued and outstanding. As a result of the Exchange, NVI became a wholly-owned subsidiary of ECMM. The ECMM shares were issued to the NVI Shareholders on a pro rata basis, on the basis of 4,000 shares of the Company’s Common Stock for each share of NVI common stock held by such NVI Shareholder at the time of the Exchange

http://sec.gov/Archives/edgar/data/1379006/000114420406047712/v057372_10sb.htm

[BonelessCat]

So, you think $4 million over 6 years is excessive? You think $667k a year for cost of development and license fees is too much? You think $50k a month for fees that include R&D, salaries for at least 3 employees, and the cost of materials is over charging?